AcquisitionOther
Eli Lilly and Company acquired Ventyx Biosciences, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Eli Lilly and Company -> Ventyx Biosciences, Inc. · $1.2 billion
To advance oral therapies targeting inflammatory-mediated diseases and strengthen ability to deliver advances for patients.
Open source record (SEC) ↗